SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.56
arrow_downward
-3.70%(-0.060) 1D
$1.53
arrow_downward
-1.92% (-0.030)bedtimeAfter hours
Closed: Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.60
High
$1.77
Low
$1.50
Mkt. cap
889.24K
Avg. vol.
1.68M
Volume
216.93K
52-wk high
$16.30
52-wk low
$1.43
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
Open
$1.60
High
$1.77
Low
$1.50
Mkt. cap
889.24K
Avg. vol.
1.68M
Volume
216.93K
52-wk high
$16.30
52-wk low
$1.43
EPS
-$2.80
Beta
2.08
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
CarePlus VietNam
·
1 week ago
Scinai Immunotherapeutics (SCNI) Q4 2023 Earnings: Narrower-than-Expected Loss of -$0.47 per Share, Yet Shares Slip 8.6% - Earnings Season Preview
CarePlus VietNam
·
1 month ago
SCNI Q4 2023 Earnings: Narrower-Than-Expected Loss of -4.7 per ADS - Earnings Analysis
CarePlus VietNam
·
2 months ago
SCNI Q4 2023 Earnings: Narrower-than-Expected Loss Lifts Shares - Revenue Recognition Risk
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR